A prostate tumor targeted expression of a superantigen gene is provided, and more particularly, a preparation method of a prostate tumor-targeted double-regulated oncolytic adenovirus expressing a superantigen gene is provided, which belongs to the technical field of gene therapy. According to the preparation method, using the gene engineering technology, a staphylococcal enterotoxin A (SEA) gene is cloned into an oncolytic adenovirus vector to limit its proliferation and expression merely in prostate tumor cells, so as to achieve the purpose of targeting and killing prostate tumor cells and the tumor-specific replicative adenovirus vector is regulated by a prostate-specific antigen promoter (PSAP) and the telomerase reverse transcriptase promoter, so as to carry a SEA gene fragment and to be named as SG504-SEA, which has both specific proliferation capacity in tumor cells and strong cytotoxic T lymphocyte (CTL) stimulating capacity.
